The AP-1 transcription factor is composed of a mixture of homo-and hetero-dimers formed between Jun and Fos proteins. The dierent Jun and Fos family members vary signi®cantly in their relative abundance and their interactions with additional proteins generating a complex network of transcriptional regulators. Thus, the functional activity of AP-1 in any given cell depends on the relative amount of speci®c Jun/Fos proteins which are expressed, as well as other potential interacting proteins. This diversity of AP-1 components has complicated our understanding of AP-1 function and resulted in a paucity of information about the precise role of individual AP-1 members in distinct cellular processes. We shall discuss recent studies which suggest that dierent Jun and Fos family members may have both opposite and overlapping functions in cellular proliferation and cell fate. Oncogene (2001) 20, 2378 ± 2389.
Introduction
The AP-1 transcription factor participates in the control of cellular responses to stimuli that regulate proliferation, dierentiation, immune response, cell death and the response to genotoxic agents or stress . AP-1 is composed of Jun family members (c-Jun, JunB, and JunD) that can form either homo-or hetero-dimers among themselves. Jun proteins also dimerize with Fos family members (c-Fos, FosB, Fra1 and Fra2) (Angel et al., 1987 (Angel et al., , 1988a Curran and Franza, 1988; Halazonetis et al., 1988; Sassone-Corsi et al., 1988; . Jun and Fos proteins also dimerize eciently with other transcription factors such as members of the ATF/ CREB (Hai and Curran, 1991) or Maf/Nrl (Kataoka et al., 1994; Kerppola and Curran, 1994 ) families of proteins.
The diferent members within the Jun or Fos families of proteins share a high degree of sequence homology. Experiments based on the use of deletion and chimeric constructs of Jun and Fos proteins have revealed the modular nature of their structure. Both families belong to the bZIP group of DNA binding transcription factors. These proteins are characterized by a highly charged, basic DNA binding domain, immediately adjacent to an amphipathic dimerization domain, referred as the`Leucine zipper' (Kouzarides and Zi, 1988; Landschulz et al., 1988) . Dimerization is required for speci®c and high anity binding to the palindromic DNA sequence, TGAC/GTCA (Rauscher et al., 1988; Gentz et al., 1989; Ransone et al., 1989; Schuermann et al., 1989; Turner and Tjian, 1989) . The dierent AP-1 dimers exhibit similar DNA binding speci®cities but dier in their transactivation eciencies (Chiu et al., 1989; Kerppola and Curran, 1991b; Suzuki et al., 1991) . The N-terminal transactivation domain is more divergent and may account for the distinct transactivation properties of the Jun proteins. c-Jun contains a docking site for the Jun N-terminal kinases (JNKs) which phosphorylate Serines 63 and 73 thereby enhancing its transcriptional potential and stability (Smeal et al., 1991) . The JunB protein contains a JNK docking site but lacks N-terminal acceptor serine residues (Chiu et al., 1989 ) still a recent study claims that JunB can be phosphorylated by these kinases (Li et al., 1999) . JunD lacks a functional JNK docking site (Kallunki et al., 1996) and is not phosphorylated by these kinases. Nevertheless, JunD contains an acceptor Serine and can be phosphorylated by JNK in c-Jun/ JunD heterodimers (Kallunki et al., 1996) .
Comparison of c-Jun sequences among species reveals high degree of homology. The sequence of the mouse c-Jun protein shares 96, 81 and 72% identity with its human, chick and Xenopus counterparts, respectively ( Figure 1 ). The C-terminal part of the cJun protein containing the basic region and the Leucine-zipper is totally conserved amongst these species while divergences are observed in the N-terminal transactivation domain. When compared with the Drosophila Melanogaster Jun protein, sequence identity falls to 25% but remains highly similar (60%) in the bZip region. This observation prompted us to search for an homologous sequence in Caenorhabditis Elegans. We found a bZip-containing Blast sequence which has 34% identity and 54% similarity with the mouse bZip domain. Moreover, as previously shown, the bZip domain found in the Pap1 protein, an AP-1 member of the ®ssion yeast S. Pombe, has 27% identity and 46% similarity with its murine counterpart (Figure 1) .
The relative binding anities of distinct dimer combinations depend on the speci®c DNA sequence and on the promoter context (Halazonetis et al., 1988; Kerppola and Curran, 1991a; Ryseck and Bravo, 1991) . Such binding sites were identi®ed in viral enhancers and promoters, including the polyomavirus (Piette et al., 1987) and papillomavirus (Thierry et al., 1992; Bouallaga et al., 2000) . Many other AP-1 binding sites have been characterized in promoters or enhancers of cellular genes encoding enzymes involved in tissue remodelling, like collagenase and stromelysin, in cell cycle controlling genes such as cyclin D1 or c-jun itself, in cytokine encoding genes like IL2 (for reviews see Vogt and Bos, 1990; Angel and Karin, 1991) .
The role of AP1 in the control of cell proliferation was extensively investigated, mostly at the cellular level. Several lines of evidence suggest that the Jun and Fos proteins are important targets for mitogenic signal transduction pathways. First, the AP-1 binding sequence was originally identi®ed as a TPA responsive element (TRE) and was shown to respond to the tumour promoter, TPA. Treatment of cultured cells with mitogenic agents resulted in a strong increase in AP-1 binding to a TRE sequence (Piette et al., 1988; Angel and Karin, 1991) . Upon serum stimulation, many quiescent cells displayed an increase in c-jun, junB and fos mRNAs (Herschman, 1991) . Based on their rapid, high and transient transcriptional upregulation in response to mitogenic agents, these agents were de®ned as`immediate early genes' or`competence genes' and encode products necessary for entry into G1 and S phases of the cell cycle (Lau and Nathans, 1987; Almendral et al., 1988) . In the following sections, we will review the function of the three members of the Jun family in dierent biological processes.
I-mitotic response

From G0 to G1
Proto-oncogenes frequently participate in the regulation of cell proliferation through signal transduction pathways which convert extra-cellular stimuli into gene expression programs. Many of these genes are also activated during the G0 to G1 transition when quiescent cells are stimulated by mitogens to re-enter the cell cycle. To follow carefully the dierent components of AP-1 during cell growth, our laboratory has produced polyclonal and monoclonal antibodies speci®c for each member of the Jun and Fos families of proteins. These antibodies provided valuable tools to determine the relative concentration and the potential dimer combinations under speci®c cellular growth conditions. We have ®rst analysed the variations of the Jun and Fos protein levels and AP-1 activity in normally cycling, resting and stimulated cells . This study allowed us to classify these proteins into three sub-groups, according to their Figure 1 Sequence alignment of c-Jun proteins among dierent species. Mouse c-Jun protein is aligned with its human, chicken Xenopus and Drosophila counterparts. We have also added the sequence of Pap1, referred as the AP-1 member in the ®ssion yeast S. Pombe as well as the sequence of abZip-containing Blast sequence found in C. Elegans (accession number in GenBank: CAA90948.1). Each amino acid is de®ned by its one letter-code. A colour code is also used to better illustrate the similarities between c-Jun proteins. It is described as follows: short side chains amino acids (A, G) in dark blue, hydrophobic residues (V, L, P, I, M) and aromatic amino acid (F, W, Y) in green, charged amino acids (including basic residues ± R, K, H ± and acidic residues ± D, E ± in red) and nucleophilic (S, T), amide (N, Q) and cystein residues in purple. Phosphorylated Serines 63 and 73 are pointed by stars and DNA binding domain (DNA BD), nuclear localization signal (NLS) and dimerization domain are also indicated Oncogene The mammalian Jun proteins: redundancy and specificity F Mechta-Grigoriou et al expression patterns c-Jun, JunD and Fra-2 are expressed in cycling mouse ®broblasts and are only mildly induced upon serum addition to the growing cells. When cells become quiescent upon serum starvation, c-Jun level decreases and JunD level increases. JunD is partially degraded upon seruminduced re-entry into the cycle while c-Jun is strongly stimulated under these conditions. In contrast to the ®rst group, the basal level of JunB, c-Fos, FosB and DfosB proteins is low in cycling mouse ®broblasts but strongly and rapidly increases after serum stimulation. Fra1 is the only member of the third group. Undetectable in cycling cells, Fra-1 stimulation following serum addition is delayed to later time points and it was shown to be transcriptionally activated by c-Jun/cFos dimers. The AP-1 DNA binding activity follows the kinetic of Jun and Fos protein accumulation after serum stimulation and the composition of AP-1 dimers involved in DNA binding re¯ects their respective abundance. These experiments completed data from earlier studies on the G0 to G1 transition in SWISS-3T3 ®broblasts Bravo, 1991a, 1992) . These authors also showed that the amount of each Jun and Fos protein governs the relative proportion of the dierent dimers at any time. Finally, serum or mitogen stimulation activates also pre-existing AP-1 complexes through post-translational modi®cations. All Jun and Fos proteins are phosphorylated following their synthesis or after mitogenic stimulation suggesting that both transcriptional and post-transcriptional mechanisms are involved in the regulation of Jun and Fos proteins.
In summary, AP-1 composition and activity are strikingly controlled at the G0 to G1 transition involving both protein synthesis and post-translational modi®cations. The dierent combinations of the AP-1 complex and the surrounding DNA sequences determine the binding anity for a given TRE. As discussed further, AP-1 target genes are dierently regulated by distinct AP-1 dimers. As a consequence, AP-1 composition would determine the speci®c pattern of target gene expression and allow prediction on the nature of the dimeric combinations which are physiologically relevant under various conditions. Very few of the AP-1 target genes activated during the G0 to G1 transition were identi®ed. One of them is cyclin D1 that will be discussed below.
Cell cycle
Progression through the cell cycle is tightly controlled by the sequential activation of a genetic program including the synthesis of the cyclins and the activation of the cyclin-dependent kinases (cdk). Few examples of cross talk between transcription factors and cell cycleregulated kinases have already been described. Among them the E2F factor is activated by the phosphorylation and release of its negative regulator pRb by CdkCyclins. Free E2F promotes cell cycle progression by activating the synthesis of cyclins and of proteins essential for DNA replication including histones, DNA polymerase a and g subunits, thymidine kinase etc. AP-1 binding sites are also found in regulatory sequences of cell cycle speci®c genes. For instance, the cyclin D1 gene is directly regulated by AP-1 and links it to the cell cycle progression. Thus, the AP-1 transcription factor does not only mediate the transduction of extracellular stimuli in the G0 to G1 transition but may also provide a speci®c function in normally cycling cells. c-Jun: positive regulator of cell cycle The involvement of c-Jun in promoting normal cell growth has been ®rst documented by the use of neutralizing antibodies or anti-sense RNA which block entry into S phase (Kovary and Bravo, 1991b; Riabowol et al., 1992; Smith and Prochownik, 1992) . Moreover, overexpression of c-Jun alters cell cycle parameters and increases the proportion of cells in S, G2 and M relative to G1 phases of the cell cycle (Pfarr et al., 1994) . The role of c-Jun in promoting cell growth has been further highlighted from studies of c-Jun de®cient mouse embryonic ®broblasts (Hilberg et al., 1993; Johnson et al., 1993) . Fibroblasts lacking c-Jun exhibit a severe proliferation defect. Cyclin D1 is only poorly activated in these cells leading to an inecient progression from G1 to S phase and cell cycle block (Wisdom et al., 1999) . Moreover, c-Jun de®cient ®broblasts accumulate the tumour suppressor p53 and its downstream target, the cyclin-dependent kinase inhibitor p21, suggesting that one particular function of c-Jun is the negative regulation of p53 transcription in ®broblasts (Schreiber et al., 1999) . These observations link directly c-Jun dependent signalling to the cell cycle machinery and demonstrate that c-Jun transduces a mitogenic response through two dual signalling pathways. On one hand, it activates cyclin D1 transcription and, on the other hand, it inhibits p21 accumulation through repression of p53 expression. In this context, it is important to mention a recent study on the role of c-Jun in the mammalian UV-response. This study shows that cells lacking c-Jun undergo a cell cycle arrest in response to UV irradiation whereas cells expressing c-Jun constitutively exhibit an increased clonogenic potential as well as an increased apoptotic response. These results demonstrate that c-Jun is necessary for UV-irradiated cells to escape from p53-dependent growth arrest and to re-enter the cell cycle (Shaulian et al., 2000) .
JunB and JunD: negative regulators of the cell cycle The protein level of the dierent AP-1 members is dierently modulated during the cell cycle. The analysis of c-Jun and JunB proteins in exponentially growing Hela or 3T3 cells showed that the level of cJun remains constant during the cycle whereas JunB protein level decreases during mitosis. The reduction of JunB levels during the G2/M transition is the consequence of its phosphorylation by the p34 cdc2 -cyclin B kinase complex followed by its proteolysis. In contrast, c-Jun undergoes N-terminal phosphorylation during this transition increasing its transcriptional activity (Bakiri et al., 2000) . JunB exhibits a decreased dimerization propensity and a weaker DNA binding
The mammalian Jun proteins: redundancy and specificity F Mechta-Grigoriou et al activity than c-Jun. Thus, JunB is a less potent transcriptional activator than c-Jun, and it was shown to repress c-Jun-mediated transactivation, most likely by formation of inactive c-Jun/JunB dimers (Deng and Karin, 1993) . In fact, c-Jun and even more phospho-cJun are strong activators of the cyclin D1 promoter. On the contrary, JunB inhibits its transcription in cotransfection experiments. The c-Jun/JunB protein ratio is thus an important parameter for the control of AP-1 target gene expression, including cyclin D1. The decrease in the abundance in JunB at the beginning of G1 and the transient phosphorylation of c-Jun during this time will generate a wave of cyclin D1 transcription (Bakiri et al., 2000) . In another recent study, p16
INK4a was identi®ed as a direct transcriptional target of JunB. Induction of p16
INK4a expression leads to inhibition of cyclin Ddependent kinase activity and reduced pRb phosphorylation state which in turn extends G1 phase length.
Stimulation of p16
INK4a transcription de®nes JunB as a direct negative regulator of cell proliferation (PasseÂ gue and Wagner, 2000) . In essence, JunB negatively regulates G1/S transition by two distinct mechanisms, inhibition of cyclin D1 transcription by competing with c-Jun and activation of p16
INK4a
. In this context, it is important to mention that, in dermal ®broblasts, c-Jun and JunB display antagonistic functions on keratinocyte proliferation and dierentiation. The relative amounts of c-Jun and JunB regulate the regeneration and maintenance of the epidermal tissue by acting as positive or negative mediators of IL1-regulated cytokine expression, such as KGF or GM-CSF. In ®broblasts, JunB suppresses directly or indirectly the expression of these genes whereas c-Jun is required for the expression of both secreted cytokines which control keratinocyte proliferation and dierentiation (Szabowski et al., 2000) .
Similarly to JunB, overexpression of JunD in immortalized ®broblasts slows down the proliferation of the cells and induces their accumulation in G1 (Pfarr et al., 1994) . Moreover, JunD 7/7 immortalized ®bro-blasts display higher proliferation rates than their wild type counterparts. However, as discussed below, JunD is still essential for the survival of primary mouse embryonic ®broblasts . JunD may act as a negative regulator of cell growth by establishing or maintaining the cells in a quiescent state. In ovarian follicles, JunD expression correlates with the transition from proliferating granulosa cells to dierentiated growth arrested luteal cells and may play a critical role in terminating cell proliferation (Sharma and Richards, 2000) .
In conclusion, c-Jun and JunB or JunD display opposite eects on cell cycle progression. While c-Jun is a strong transcriptional activator of cyclin D1, JunD is a weak positive activator and JunB even an inhibitor of this promoter. Increasing the abundance of JunB or JunD relative to c-Jun decreases cyclin D1 transcription. The temporal changes in AP-1 composition and activity during the M-G1 transition may constitute an interesting way to control cell cycle progression. The cell cycle dependent variations in Jun protein levels constitute a novel reciprocal link between the cell cycle machinery and a transcription factor (Bakiri et al., 2000) .
Cellular transformation
Constitutive activation of growth-promoting signalling pathway leads to partial transformation of cells. The Ras proteins play a key role in signal transduction and regulation of cell proliferation (Mulcahy et al., 1985; Feig and Cooper, 1988; Smith et al., 1989) . Their mutation leads to abnormal proliferation and is frequently associated with human tumours. Mitogenic signal transduction initiated by activation of growth factor receptor leads to conversion of Ras into its GTP-bound active form. The best characterized target for the membrane-tethered Ras proteins is the Raf protein kinase, involved in the control of MAPKK (Mitogen-activated protein kinase kinase) cascade, which, in turn, activate the Erk (Extracellular regulated kinase) members of the MAP kinase family. Ras partially activates also the JNKs. Several lines of evidence suggest that AP-1 transmits signals from activated Ras to the nucleus in transformed cells. c-Jun: Positive regulator of Ras-mediated transformation Ras-transformation is correlated with increased c-Jun transcriptional activity and an increase in AP-1-mediated gene expression (Alani et al., 1991; Westwick et al., 1994) . Blocking AP-1 activity using dominant negative forms of c-Jun or c-Fos proteins partially reverts the transformed phenotype of Ras-overexpressing ®broblasts (Lloyd et al., 1991; Suzuki et al., 1994) . The induction of AP-1-responsive genes by Ras is severely impaired in c-jun 7/7 ®broblasts. Ras-expressing c-jun 7/7 cells lack transformed traits, including loss of contact inhibition, anchorage independence and tumorigenicity in mice showing that c-Jun is required for Ras-driven malignant conversion (Johnson et al., 1996) . Deregulated expression of c-Jun or its viral counterpart v-Jun triggers transformation in avian primary embryo ®broblasts (Vogt et al., 1989; Castellazzi et al., 1990) . Although overexpression of c-Jun alone leads to partial transformation of mouse ®broblasts (SchuÈ tte et al., 1989) , the coexpression of both c-Jun and Fra1 strongly increases the transformed traits. Hence, ectopic co-expression of c-Jun and Fra-1 in ®broblasts leads to a transformed phenotype with properties reminiscent of that of Rastransformed cell lines (Mechta et al., 1997) . The intrinsic transforming capacity of c-Jun and Fra-1 suggests that these two AP-1 members are crucial in establishing Ras-mediated transformation of NIH3T3 ®broblasts. An elegant study has addressed the contribution of the dimer partner into the c-Jundependent transformation and showed that c-Jun mediated transformation acts by two distinct pathways controlling either anchorage independence or autocrine growth, depending on its associated partner. In the ®rst case, ATF2 is the dimerization partner while for the Oncogene The mammalian Jun proteins: redundancy and specificity F Mechta-Grigoriou et al second it involves Fos or Fra proteins (van Dam et al., 1998) .
Simultaneous overexpression of c-Jun and c-Fos in bone enhances the rate of osteosarcoma formation, suggesting that c-Jun and c-Fos proteins cooperate in vivo in bone tumour development (Wang et al., 1995) . These data illustrate that the c-Jun containing AP-1 dimers are essential downstream eectors for the Ras signalling pathway in cellular transformation, as well as important players in multi-step carcinogenesis.
JunB and JunD: negative regulators of Ras-mediated transformation Members of the AP-1 family are dierently regulated by constitutive oncogenic Ras expression. While stable Ras-transformed ®broblasts accumulate higher levels of c-Jun, junB, Fra-1 and Fra-2 proteins relative to their normal counterparts (Mechta et al., 1997) , JunD protein level decreases strongly in Ras-transformed ®broblasts (Pfarr et al., 1994) . Moreover, in these cells, serum inducibility of JunB and Fra2 is markedly attenuated whereas the elevated levels of c-Jun and Fra-1 remain constant under these conditions. Furthermore Ras signalling leads to a complete loss of serum inducibility of c-Fos and FosB (Mechta et al., 1997) . Selective and sustained MAPK activation induces also speci®c AP-1 members like c-Jun whereas persistent activation of MAPK is not sucient to induce c-fos (Cook et al., 1999) .
Besides their antagonistic roles on normal cell proliferation, a striking dierence in response to Ras signalling between c-Jun and JunD was observed in ras-transformed ®broblasts. The ratio of c-Jun to JunD proteins in such cells correlates with the severity of the transformed phenotype. While c-Jun co-operates with Ras, excess JunD partially suppresses the transformed phenotype (Pfarr et al., 1994) . Moreover, in cell lines derived from bovine-papillomavirus-induced tumours in mice, the c-Jun to JunD ratio increases as cells progress from aggressive ®bromatosis to malignant ®brosarcoma (Bossy-Wetzel et al., 1992) . The down regulation of JunD protein in dierent transformed cell systems is consistent with the hypothesis that JunD functions as an inhibitor of cell proliferation. For instance, in human ovarian tumours, the expression level of junD is down-regulated when compared with normal ovarian epithelial cells (Neyns et al., 1996) . Moreover, c-Jun protein is barely undetectable in normal mucosa whereas JunD protein is expressed at high level. Finally, while c-jun expression is signi®-cantly increased in human colorectal adenocarcinoma, junD expression remains steady suggesting antagonistic roles of c-Jun and JunD in epithelial cell growth and colorectal tumorigenesis. In this context it is important to recall that JunD interacts with Menin encoded by the Men1 (Multiple Endocrine Neoplasia type 1) tumour suppressor gene. Menin inhibits the transcriptional activity of JunD. This provides an intriguing link between junD and growth control in vivo (Agarwal et al., 1999) . It is possible that in cell types giving rise to this tumour, JunD acts as a positive regulator of growth. Alternatively, the inactivation of Menin may aect the capacity of JunD to control p19
Arf (see below). JunB is another Jun member that antagonizes the Ras-signalling pathway. Avian cells overexpressing JunB develop colonies in agar with a reduced eciency than c-Jun and do not grow in low-serum containing medium (Castellazzi et al., 1990) . Moreover, in mice, JunB inhibits Ras-and Src-mediated neoplastic transformation and tumour growth by increasing p16 All these observations suggest that temporal and qualitative modulation of AP-1 composition provides a paradigm of speci®city in target gene regulation in dierent cell-transformation processes (Figure 2 ). Ras transformation increases the cyclin D1 protein level, a major regulator of the G1/S transition previously identi®ed as an AP-1 target gene. Increased cyclin D1 expression in Ras-transformed cells shortens their G1 phase (Liu et al., 1995; Robles et al., 1998) . Moreover, overexpression of cyclin D1 in immortalized ®broblasts accelerates G1 progression and decreases serum requirement for growth. Thus, transformation by Ras leads to accumulation and activation of AP-1 transcription factor that in turn increases cyclin D1 protein level and accelerates G1 progression. AP-1-mediated induction of cyclin D1 explains how changes in AP-1 composition mimic in part the proliferative eects of activated Ras. Dierences in the transcriptional activities of JunB and JunD in comparison with cJun explain how the two ®rst antagonize proliferation and Ras-mediated transformation by dierently regulating cell cycle regulators like cyclin D1 (Pfarr et al., 1994; Mechta et al., 1997; Bakiri et al., 2000) . In agreement with this hypothesis, JunB was shown to inhibit the transforming activity of a c-Jun (Schutte et al., 1989) . In conclusion, junB and JunD proteins function as a buer of Ras oncogene and modulate their potent c-Jun partner hence decreasing its harmful eects.
Figure 2 Schematic representation of cell cycle gene regulation by Jun proteins
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Apoptosis and senescence
Apoptosis or programme cell death is commonly used to eliminate damaged or non essential cells during development, to maintain tissue homeostasis or to eliminate oncogene-expressing cells in adult organisms. Numerous studies have shown that AP-1 is involved in the onset or control of apoptosis. AP-1 can trigger both pro-or anti-apoptotic signals depending on the dimer composition, the cell types or the death-inducing treatments.
c-Jun: pro-apoptotic gene c-jun expression is induced in response to treatments which frequently triggers apoptosis, among them UV, ionizing radiation, hydrogen peroxide and Tumour Necrosis Factor a (TNFa) (Brenner et al., 1989; Devary et al., 1991; Manome et al., 1993) . c-jun and c-fos expression is also upregulated in lymphocytes that undergo apoptosis in response to IL6 depletion and c-jun or c-fos antisense oligonucleotides protect these cells from death response (Colotta et al., 1992; Preston et al., 1996) . Other data strongly suggest that increased c-Jun activity (phosphorylation and neosynthesis) mediates apoptosis in neurons, after removal of survival factors (Watson et al., 1998) . c-Jun mediates the neuronal dierentiation eects of NGF on PC12 cells (Xia et al., 1995) . In dierentiated PC12 cells, removal of NGF triggers the JNK signalling pathways and results in apoptosis of the cells (Leppa et al., 1998) . Overexpression of c-Jun in sympathetic neurons induces apoptosis while a dominant-negative mutant of c-Jun blocks Nerve Growth Factor (NGF) withdrawal-induced programmed cell death (Estus et al., 1994; Ham et al., 1995) . Moreover, c-Jun accumulates in neurons undergoing apoptosis by hypoxia in vivo (Dragunow et al., 1993) . Amino-terminal phosphorylation of c-Jun is also required for ceramide-induced apoptosis of myeloid or lymphoid tumour cell lines (Verheij et al., 1996) and neuronal stress-induced apoptosis in vivo (Behrens et al., 1999) . Finally, inducible c-Jun protein transmits an apoptotic death signal to immortalized ®broblasts that can be antagonized by Bcl-2. This pro-apoptotic eect is speci®c of c-Jun and is not observed with JunB inducible constructions (Bossy-Wetzel et al., 1997) . All these results provide evidence that c-Jun is a potent inducer of programmed cell death in various cell types.
c-Jun: anti-apoptotic gene Although a number of reports showed that AP-1 and JNK are involved in apoptosis, other data argue that they are not essential for cell death c-Fos appears to be anti-apoptotic in UV irradiated immortalized ®broblasts (Schreiber et al., 1999) whereas c-fos de®cient mice undergo normal developmental apoptosis (Gajate et al., 1996) . c-Jun
embryos exhibit higher rates of apoptosis in liver than control animals (Eferl et al., 1999) and c-Jun is not essential for programmed cell death and axon growth in the retina (Herzog et al., 1999) . Moreover, in Jurkat cells, AP-1 is not increased during Fas-mediated cell death although Fas cross linking leads to Ras induction and JNK activation (Lenczowski et al., 1997) . Furthermore, AP-1 regulates directly the murine anti-apoptotic Bcl-3 gene, which acts as a survival factor for T cells in the absence of growth factors (Rebollo et al., 2000) . In TNFa-treated HeLa cells, blocking MAPK cascade prevents JNK activation without aecting apoptosis (Liu et al., 1996) claiming that JNK activation is not associated with TNFamediated apoptosis. Finally, analysis of mice lacking both jnk1 and jnk2 assign both pro-and anti-apoptotic functions to these kinases in early brain development (Kuan et al., 1999; Sabapathy et al., 1999) . The role of c-Jun in apoptosis is thus complex, mostly cell-type speci®c and depends on the nature of the death-inducing signal. One current hypothesis to explain these apparent contradictory results links c-Jun containing AP-1 dimers to de novo protein synthesis. Hence, it has been shown that an active pro-apoptotic machinery pre-exists in the cells. AP-1 activity would be required for apoptosis in cells in which the death eectors are present in limiting amounts and in which protein synthesis is required to initiate the apoptotic suicide program (Karin et al., 1997) .
JunB and JunD: apoptosis and senescence programs The study of JunD 7/7 primary embryonic ®broblasts showed that these cells undergo premature replicative growth arrest, also named senescence, and displayed increased sensitivity to death-promoting agents, including UV irradiation or TNFa treatment . JunD protects normal cells from senescence or from apoptosis induced by stress stimuli by modulating a p53-dependent pathway. JunD 7/7 ®broblasts exhibit increased levels of p19
Arf . p19
Arf sequesters Mdm2 blocking its capacity to promote p53 degradation. Thus the increased level of p19
Arf in JunD 7/7 cells leads to accumulation of p53 in the nucleus and to increased sensitivity to proapoptotic signals. Moreover, the anti-apoptotic eect of JunD was con®rmed in vivo in TNFa-induced hepatic cell death. JunB overexpressing primary ®broblasts exhibit an increased p16
INK4a protein level, block cell cycle and also undergo premature senescence (PasseÂ gue and Wagner, 2000) . JunB decreases the proliferation rate of primary ®broblasts by bringing up the p16
INK4a known to favour the premature onset of senescence (Serrano et al., 1997) .
In conclusion, these data suggest that the dynamic changes in Jun and Fos composition after stress-stimuli balance between distinct signals, including pro-or antiapoptotic pathways, that play a key role in de®ning whether cells undergo senescence, apoptosis or survival.
Regulation of Juns by signalling pathways
The biological function of AP-1 was initially restricted to the transmission of growth promoting signals. Stimulation of dierent signal transduction pathways led to the onset of distinct transcription programs and genes encoding Jun and Fos protein underwent similar, but not identical, regulation in response to various Oncogene The mammalian Jun proteins: redundancy and specificity F Mechta-Grigoriou et al stimuli. The expression of jun and fos gene products is temporally modulated suggesting that the AP-1 composition vary in the cell as a function of time and stimulus but also according to the cellular dierentiation state and its environment. De®ning how the dynamic transcription factor AP-1 responds to dierent environmental cues is an important issue in an eort to understand their respective functions.
Regulation of c-Jun The c-jun gene is expressed in many dierent cell types at low levels and its expression is enhanced in response to many stimuli including TPA (in a protein-kinase C-dependent manner), growth factors (EGF, NGF, FGF), UV irradiation or cytokines (Hill and Treisman, 1995; Karin and Hunter, 1995) . The c-jun promoter region is highly conserved between mouse, rat and human and the 200 nucleotides upstream of the murine and human transcription initiation site share 94% identity . The c-jun promoter contains potential binding sites for several transcription factors, including SP1 (Rozek and Pfeifer, 1993), NF-Jun (Nuclear factor-jun) (Brach et al., 1992) , CTF (CCAAT Transcription Factor) and AP1 itself (Angel et al., 1988b) . Induction of c-jun expression by serum, phorbolester, or TGFb is mediated through a TRElike site (jun1) located in the proximal region of the murine c-jun regulatory sequences. This TRE sequence diers from the consensus TRE by one base pair insertion and is preferentially recognized by a c-Jun/ ATF2 heterodimer rather than a conventional cJun/cFos AP-1 dimer (van Dam et al., 1993) . In the distal part of the c-jun promoter, a second AP-1 like site (jun2) also mediates the c-jun responsiveness to TPA or insulin treatment and growth factor stimulation (Stein et al., 1992; Hagmeyer et al., 1993) . The jun2 site also binds c-Jun/ATF2 heterodimers. As ATF2 alone cannot confer TPA-inducibility of c-jun, the c-jun gene is thus up-regulated by its own product. Despite its inducible expression, most cell types contain a certain basal level of c-Jun protein prior to stimulation and the TRE site in its promoter is constitutively occupied (Angel et al., 1988b; Rozek and Pfeifer, 1993) . Following exposure to stimuli, the N-terminal Jun Kinases (JNK), members of the MAPK family, are activated leading to the rapid phosphorylation of preexisting c-Jun and ATF2 proteins (Devary et al., 1992; Gupta et al., 1995) . Phosphorylation of c-Jun on residues Ser63 and Ser73, located within its transactivation domain, potentiates its transactivation properties by recruiting the coactivator protein, CBP, a histone acetylase (Arias et al., 1994) , thereby enhancing c-jun transcription. Thus, stimulation of AP-1 activity in response to JNK-mediated stimuli (such as UV irradiation, ras activation, NGF removal or TNFa treatment) proceeds through two distinct steps: endogenous basal c-Jun protein is ®rst activated by posttranslational modi®cations and the phosphorylated form of c-Jun induces subsequently its own transcription by a positive auto-regulatory loop. The JNKs are the only kinases which activate speci®cally c-Jun; Erk1 and Erk2 MAPKs (mostly stimulated by growth factors or phorbol esters) are inecient in phosphorylating the N-terminal part of c-Jun although they have been shown to phosphorylate a cluster of inhibitory residues located next to the basic domain.
Regulation of JunB Sequence analysis of the junB promoter reveals several potential regulatory elements, well conserved amongst rat, mouse and human sequences (Kawakami et al., 1992) . These include Stat3 (Coer et al., 1995) , CRE, SRE (Kitabayashi et al., 1993) and CAAT enhancer binding domains. An IL6 (Interleukine-6) regulatory region containing an inverted repeat (IR) was ®rst identi®ed as conferring phorbol-ester and protein kinase A inducibility of the junB gene (de Groot et al., 1991a) . A GC-rich area provides potential binding sites of several transcription factors including SP1 or Krox-24 (Egr1) but its function is not yet completely established. A SRE1 sequence (Serum Responsive Element) confers junBinducibility to growth factors and recruits ternary complex factor (TCFs). Another SRE site (SRE2) located distantly and functionally distinct from SRE1, as it does not respond to growth factor, suggests that junB regulation proceeds through a complex interplay between proximal and distal regulatory regions (Phinney et al., 1994) .
JunB diers in biological properties from its homologue c-Jun and was de®ned as a negative regulator of cell growth. This functional dierence is due to changes in amino-acid sequences which decrease its dimerization potential (see above) and eliminate the JNK phosphorylation sites, and therefore decrease its transactivation potency. First, elevation of cAMP concentration arrests 3T3 ®bro-blasts in mid-G1 of the cell cycle and regulates dierently c-Jun and JunB. While c-Jun expression is completely inhibited, JunB expression is induced in response to PKA (cAMP-dependent Protein Kinase) activation . The negative eect of JunB on cell proliferation is also consistent with its induction by inhibitors of cell growth such as TGFb (Transforming Growth Factor b) or inhibitors of myogenic dierentiation, like BMP2 (bone Morphogenetic Protein), which alters cell lineage from the myogenic to the osteogenic lineage (Chalaux et al., 1998) . Smad proteins were identi®ed as downstream eectors of the TGFb-dependent signal transduction pathway. Smad binding elements (CAGACA) that mediate responsiveness to several members of the TGFb family were identi®ed within the junB promoter (Jonk et al., 1998; Lopez-Rovira et al., 2000) . Multimerization of this element leads to a strong TGFb inducible enhancer that is also responsive to BMPs suggesting that this speci®c site mediates junB induction in response to TGFb and BMP treatments.
The junB gene belongs to the immediate early genetic response of leukaemic myeloid (M1) cells to IL6, a cytokine which induces dierentiation and growth arrest in these cells. The analysis of junB induction in
The mammalian Jun proteins: redundancy and specificityresponse to IL6 revealed that the cis-acting elements involved may be cell-type speci®c. The Stat3 and CRElike binding sites in the junB promoter are required for IL6 responsiveness in HepG2 liver cells (Nakajima et al., 1993) . Conversely, the CAAT box and the IR were identi®ed as IL6-response element in M1 cells. These sites are constitutively occupied suggesting that IL6-mediated induction passes through post-translational modi®cation of pre-existing complexes (Sjin et al., 1999) .
Regulation of junD In contrast with c-jun and junB, junD is relatively refractory to serum stimulation and its basal expression remains high in many cell types. The murine junD promoter contains several identi®ed binding sites: a CRE sequence recognized by CREB/ATF family members, a Sp1 site, an octamer motif, a CAAT box, a GC-rich region recognized by Krox-24 and an AP-1 consensus sequence. The octamer motif is the major regulator of junD expression and is speci®cally recognized by the ubiquitous Oct1 protein (de Groot et al., 1991b) . Oct1 confers the high basal level of junD transcription and explains the wide distribution of its expression pattern. The AP-1 motif does not respond to TPA in the presence of the octamer motif, suggesting a negative interference between both factors. This interference may explain the low inducibility of junD in response to various stimuli. However, the TRE site is activated by JunD in the brain suggesting speci®c positive autoregulation of JunD in this tissue.
In conclusion, the transcriptional regulation of c-jun, junB and junD diers markedly in accordance with the existence of distinct regulatory elements (Figure 3) . High basal expression level of the junD gene is mediated by an octamer motif, absent in c-jun-or junB-promoters. Moreover, the basal level of c-jun expression is generally higher than that of junB in ®broblasts due to its positive autoregulatory loop. Conversely, the junB gene is the most inducible member of the jun gene family.
In vivo functions
Studies of AP-1 functions in cell culture reveal distinct functions for each member. Several groups have undertaken gene targeting strategy to investigate the function of individual AP-1 members in vivo. Inactivation of individual AP-1 members results in distinct phenotypes, suggesting distinct functions of each gene in vivo. Inactivation of Jun and Fos family members generates various phenotypes spanning from embryonic lethality to post-natal survival associated with growth retardation or behavioural defects. Disruption of c-jun, junB or fra1 results in embryonic death whereas embryos lacking either junD, c-fos or fosB genes develop normally to birth. c-jun de®cient embryos die at 13.5 days from impaired hepatogenesis (Hilberg et al., 1993; Johnson et al., 1993) . These embryos exhibit massive apoptosis in hepatoblasts and erythroblasts lineages and present malformation in the heart out¯ow tract (Eferl et al., 1999) . Embryos lacking junB or fra1 die earlier than cjun with multiple defects in extra-embryonic tissues. The JunB 7/7 lethality results from abnormal interaction between the embryonic vascular system and the maternal circulation (Schorpp-Kistner et al., 1999) . Similarly, the placental labyrinth layer of Fra1 mutant embryos is largely a-vascular with decreased number of vascular endothelial cells . Injections of junB 7/7 or fra1 7/7 ES cells into tetraploõÈ d wild type blastocysts rescued the placental defects and restored normal growth suggesting that de®ciencies in extra-embryonic tissues are the prime cause of embryonic lethality of junB 7/7 or fra1 7/7 mutants. In contrast to c-jun and junB genes, inactivation of junD does not lead to death in utero suggesting that JunD is not essential for embryonic development. Homozygotes junD 7/7 mice appear quite healthy, although they exhibit postnatal growth retardation and males display an age-dependent defect in reproduction (Thepot et al., 2000) .
The speci®city and dierences of the biological functions of each jun gene is also re¯ected by their dierential expression pattern during embryogenesis. While JunD is widely expressed (Thepot et al., 2000) , cJun and JunB are expressed in non-overlapping sites (Wilkinson et al., 1989) . c-Jun mRNA is detected throughout organogenesis in restricted cell populations within developing cartilage, gut and the central nervous system. JunB expression is observed at early stages of embryogenesis in the primitive streak region, in the neural tube and in the pre-chordal mesoderm as well as in extra-embryonic tissues (Schorpp-Kistner et al., 1999) . Later on, JunB is restricted to dierentiating epidermal cells and endodermal gut epithelium (Wilkinson et al., 1989) . Finally, JunD has a broad expression pattern (Thepot et al., 2000) . A genetic redundancy amongst this multi-gene family of transcription factor may account for the absence of phenotype in the JunD 7/7 animals. Preliminary results obtained from the intercross of c-Jun and JunD double heterozygote mice demonstrate that c-Jun 7/7 JunD 7/7 double mutants die earlier than the c-Jun 7/7 embryos suggesting a functional redundancy between c-Jun and JunD mutations during embryogenesis (F Mechta, unpublished results). Reciprocally, the low expression of junD in the liver and the extra-embryonic tissues may explain the hepatogenetic defect in c-Jun embryos. The viability of mice lacking c-Fos or FosB suggests that the Fos-related genes may have also overlapping roles.
In conclusion, determination of the phenotypic consequences of gene disruption in mice identi®es Jun and Fos speci®c functions. AP-1 members are involved in various processes including hepatogenesis, spermatogenesis, and vascularization. The lack of major defects in three AP-1-knock-out mice suggests that a genetic redundancy may exist among some members of the AP-1 multi-gene family (see also contribution by Jochum et al.).
Oncogene
Conclusions
There has been rapid progress over the past few years towards understanding the speci®c functions of each AP-1 member. In cultured cells, AP-1 has been shown to play an important role in several processes including cell cycle progression, oncogenic transformation or apoptosis by responding to stimuli or stress. AP-1 participates in the control of these processes by ®nely regulating the expression of a set of target genes (Figure 2) . It was clearly established that the anity of AP-1 for a given TRE binding site is determined by its surrounding DNA sequences and the presence of neighbouring interacting proteins. It appears that the composition of the AP-1 dimers de®nes the nature of genes that are expressed. The antagonistic roles of the dierent Jun proteins is now clearly established in various cell systems. Their relative abundance modulates speci®c gene transcription and engages cells in a precise destiny. The existence of dierent Jun proteins in vertebrates contrasts with the unique Jun partner yet identi®ed in Drosophila (Zhang et al., 1990; RiesgoEscovar and Hafen, 1997) or Xenopus (Knochel et al., 2000) . Multi-gene family may be involved in ®ne modulation of complex processes in higher vertebrates. However, the sequence of the c-Jun protein is highly conserved among these dierent species. Moreover, the isolation of a bZip containing protein domain in C. elegans suggests the potential existence of a Jun protein in this organism. In this context, it is important to recall that recent genetic studies have demonstrated that the JNK pathway is conserved among species and required for morphogenesis and dorsal closure in Drosophila (Noselli, 1998) and coordinated locomotion of motor neurons in Caenorhabditis elegans (Kawasaki et al., 1999) .
Careful examination of all the mutants animals and derived cell lines clearly demonstrated that each family member has speci®c functions. Some of these functions were better studied with primary or established cells in culture but they relate to defects occurring in vivo under stress conditions. By applying our current knowledge on in vivo concepts and through the analysis of double mutants, we will be able in the future to determine potential redundant, overlapping or antagonistic roles among jun and fos genes in vivo. The mammalian Jun proteins: redundancy and specificity F Mechta-Grigoriou et al
